在减重手术中实施ESPEN/EASO肌少症性肥胖共识标准的可行性:一项双模态影像先导研究
这项先导研究在11例接受袖状胃切除术的女性中评估ESPEN/EASO肌少症性肥胖共识标准的实施可行性,双模态DXA与MRI评估完成率100%,MRI肌肉与脂肪组织分割Dice系数分别为0.95±0.01与0.95±0.03,术后六个月体重下降29.4±25.3 kg,ASM/体重比值显示潜在诊断效用但置信区间宽。
要点
- 双模态DXA与MRI评估完成率100%,方案依从性良好。
- MRI分割肌肉Dice系数0.95±0.01、脂肪组织0.95±0.03。
- 术后六个月体重下降29.4±25.3 kg(95%CI 14.4-44.4 kg)。
核心结论
- ESPEN/EASO共识标准在减重手术人群中实施完成率100%,MRI分割精度Dice系数肌肉0.95±0.01、脂肪组织0.95±0.03。
- 该先导研究建立方法学基础,并为后续大规模验证研究以制定肥胖特异性诊断阈值和优化肌少症性肥胖评估方案展示可行性。
研究设计与样本
- 遵循CONSORT 2010先导试验扩展指南的可行性研究,分析11例接受腹腔镜袖状胃切除术的女性。
- 年龄41.3±7.9岁(95%CI 36.6-46.0岁),BMI 41.0±5.0 kg/m2(95%CI 38.0-44.0 kg/m2)。
- 采用DXA与MRI双模态评估,主要可行性结局包括双模态评估完成率、MRI分割算法性能和方案依从性。
诊断标准与关键数值
- 使用ESPEN/EASO推荐的ASM/体重截断值评估诊断效用,原文未报告具体截断值数值。
- 双模态评估完成率100%,方案依从性最佳,所有参与者完成计划评估。
- MRI分割Dice系数肌肉0.95±0.01、脂肪组织0.95±0.03。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文指出ASM/体重比值的置信区间宽,反映小样本分析固有的高度不确定性。
- 原文指出缺乏III级肥胖的验证截断值,且双模态评估方案证据有限,是临床实施的关键障碍。
- 原文结论提出需开展更大规模验证研究以制定肥胖特异性诊断阈值并优化评估方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The heterogeneous diagnostic methods for sarcopenic obesity lack standardization across clinical practice. The 2022 ESPEN/EASO consensus established standardized diagnostic criteria emphasizing weight-adjusted muscle mass indices, yet implementation feasibility in bariatric surgery populations remains unexplored. The absence of validated cutoff values for Class III obesity and limited evidence on dual-modality assessment protocols represent critical barriers to clinical implementation.
OBJECTIVE: This pilot study objectively assessed the implementation of ESPEN/EASO consensus criteria using dual-modality DXA and MRI assessment in women undergoing sleeve gastrectomy, with primary focus on protocol completion rates, technical precision, and preliminary evaluation of weight-adjusted diagnostic indices.
METHODS: Following CONSORT 2010 pilot trial extension guidelines, this feasibility study analyzed eleven women (age 41.3 ± 7.9 years (95 % CI: 36.6-46.0 years), 41.0 ± 5.0 kg/m2 (95 % CI: 38.0-44.0 kg/m2) undergoing laparoscopic sleeve gastrectomy. Primary feasibility outcomes included dual-modality assessment completion rates, MRI segmentation algorithm performance, and protocol adherence. Secondary outcomes encompassed preliminary body composition changes and ASM/weight diagnostic utility evaluation using ESPEN/EASO recommended cutoffs.
RESULTS: Dual-modality assessment achieved 100 % completion rates with excellent technical precision (MRI segmentation Dice coefficient: 0.95 ± 0.01 for muscle, 0.95 ± 0.03 for adipose tissue). Protocol adherence was optimal with all participants completing scheduled assessments. Preliminary body composition analysis demonstrated substantial weight reduction of 29.4 ± 25.3 kg (95 % CI: 14.4-44.4 kg) at six months. ASM/weight ratios showed potential diagnostic utility, though wide confidence intervals reflect substantial uncertainty inherent in small sample analysis.
CONCLUSIONS: Implementation of ESPEN/EASO consensus criteria demonstrates 100 % protocol completion rates and MRI segmentation precision with Dice coefficients of 0.95 ± 0.01 for muscle and 0.95 ± 0.03 for adipose tissue in bariatric surgery populations. This pilot study establishes the methodological foundation and demonstrates feasibility for larger-scale validation studies to develop obesity-specific diagnostic thresholds and optimize sarcopenic obesity assessment protocols in bariatric medicine.
引用
- Bužga M, Pekař M, Horká V, et al. Feasibility of implementing ESPEN/EASO consensus criteria for sarcopenic obesity assessment in bariatric surgery: A dual-modality imaging pilot study. Clin Nutr ESPEN. 2025. PMID: 41241217. doi:10.1016/j.clnesp.2025.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。